Inventor · disambiguated record
James T. Dalton
Also filed as: DALTON JAMES · DALTON JAMES T
101 granted patents·56 pending applications·2,436 citations·filing 1997–2024
99Inventor score
Files withDALTON JAMES T33UNIV TENNESSEE RES FOUNDATION31GTX INC27UNIV TENNESSEE RES FOUND19UNIV TENNESSEE RES CORP8
Top patents by PatentIndex Score
157 records- 0199US6492554B2Selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES CORP·Filed 2001·Granted Dec 10, 2002·155 cites·5 claims
- 0298US7645898B2Selective androgen receptor modulators and method of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2006·Granted Jan 12, 2010·32 cites·7 claims
- 0398US7205437B2Selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2005·Granted Apr 17, 2007·46 cites·2 claims
- 0498US6998500B2Selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2002·Granted Feb 14, 2006·106 cites·24 claims
- 0598US6995284B2Synthesis of selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2002·Granted Feb 7, 2006·124 cites·54 claims
- 0698US6569896B2Selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES CORP·Filed 2001·Granted May 27, 2003·200 cites·30 claims
- 0798US6482861B2Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancerUNIV TENNESSEE RES CORP·Filed 2000·Granted Nov 19, 2002·82 cites·5 claims
- 0898US6071957AIrreversible non-steroidal antagonist compound and its use in the treatment of prostate cancerUNIV TENNESSEE RES CORP·Filed 1997·Granted Jun 6, 2000·162 cites·15 claims
- 0997US9150501B2Solid forms of selective androgen receptor modulatorsGTX INC·Filed 2013·Granted Oct 6, 2015·19 cites·8 claims
- 1097US7772433B2SARMS and method of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2007·Granted Aug 10, 2010·51 cites·7 claims
- 1197US7622503B2Selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2005·Granted Nov 24, 2009·36 cites·23 claims
- 1297US7518013B2Selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2006·Granted Apr 14, 2009·28 cites·3 claims
- 1397US6838484B2Formulations comprising selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2002·Granted Jan 4, 2005·137 cites·85 claims
- 1497US6160011ANon-steroidal agonist compounds and their use in male hormone therapyUNIV TENNESSEE RES CORP·Filed 1998·Granted Dec 12, 2000·128 cites·9 claims
- 1597US6019957ANon-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imagingUNIV TENNESSEE RES CORP·Filed 1998·Granted Feb 1, 2000·153 cites·19 claims
- 1696US10441570B2Selective androgen receptor degrader (SARD) Ligands and methods of use thereofGTX INC·Filed 2018·Granted Oct 15, 2019·12 cites·66 claims
- 1796US10093613B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofGTX INC·Filed 2017·Granted Oct 9, 2018·9 cites·10 claims
- 1896US9814698B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofGTX INC·Filed 2016·Granted Nov 14, 2017·17 cites·47 claims
- 1996US8080682B2Substituted acylanilides and methods of use thereofDALTON JAMES T·Filed 2007·Granted Dec 20, 2011·34 cites·19 claims
- 2096US7759520B2Synthesis of selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2005·Granted Jul 20, 2010·27 cites·25 claims
- 2196US7026500B2Halogenated selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2003·Granted Apr 11, 2006·109 cites·24 claims
- 2295US10035763B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofGTX INC·Filed 2016·Granted Jul 31, 2018·15 cites·56 claims
- 2395US10017471B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofGTX INC·Filed 2016·Granted Jul 10, 2018·15 cites·45 claims
- 2495US9834507B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofGTX INC·Filed 2016·Granted Dec 5, 2017·13 cites·41 claims
- 2595US9029408B2Compounds for treatment of cancerUNIV TENNESSEE RES FOUNDATION·Filed 2013·Granted May 12, 2015·15 cites·30 claims
- 2695US8822513B2Compounds for treatment of cancerLU YAN·Filed 2011·Granted Sep 2, 2014·22 cites·36 claims
- 2795US7855229B2Treating wasting disorders with selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2005·Granted Dec 21, 2010·20 cites·12 claims
- 2895US7022870B2N-bridged selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2003·Granted Apr 4, 2006·103 cites·28 claims
- 2994US11273147B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofUNIV TENNESSEE RES FOUND·Filed 2019·Granted Mar 15, 2022·7 cites·30 claims
- 3094US9334242B2Compounds for treatment of cancerLU YAN·Filed 2010·Granted May 10, 2016·16 cites·28 claims
- 3194US8426465B2Substituted acylanilides and methods of use thereofDALTON JAMES T·Filed 2011·Granted Apr 23, 2013·19 cites·11 claims
- 3294US7741371B2Selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2006·Granted Jun 22, 2010·20 cites·7 claims
- 3393US8846756B2Substituted acylanilides and methods of use thereofDALTON JAMES T·Filed 2013·Granted Sep 30, 2014·16 cites·14 claims
- 3492US9884038B2Selective androgen receptor modulator and methods of use thereofUNIV TENNESSEE RES FOUND·Filed 2015·Granted Feb 6, 2018·3 cites·17 claims
- 3592US9447049B2Compounds for treatment of cancerGTX INC·Filed 2012·Granted Sep 20, 2016·12 cites·18 claims
- 3692US8853266B2Selective androgen receptor modulators for treating diabetesDALTON JAMES T·Filed 2007·Granted Oct 7, 2014·17 cites·5 claims
- 3792US8563606B2Solid forms of selective androgen receptor modulatorsDALTON JAMES T·Filed 2011·Granted Oct 22, 2013·14 cites·7 claims
- 3892US7344700B2Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapyUNIV TENNESSEE RES CORP·Filed 2003·Granted Mar 18, 2008·36 cites·15 claims
- 3992US7041844B2Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancerUNIV TENNESSEE RES CORP·Filed 2002·Granted May 9, 2006·30 cites·4 claims
- 4091US10301285B2Compounds for treatment of cancerUNIV TENNESSEE RES FOUND·Filed 2015·Granted May 28, 2019·6 cites·25 claims
- 4191US9844528B2SARMs and method of use thereofUNIV TENNESSEE RES FOUND·Filed 2016·Granted Dec 19, 2017·4 cites·43 claims
- 4291US9815776B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofGTX INC·Filed 2016·Granted Nov 14, 2017·13 cites·56 claims
- 4391US8008348B2Treating muscle wasting with selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2004·Granted Aug 30, 2011·31 cites·48 claims
- 4491US2024326697A1Solid forms of selective androgen receptor modulatorsUNIV TENNESSEE RES FOUND·Filed 2024·Application pending·0 cites
- 4590US10258596B2Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)GTX INC·Filed 2016·Granted Apr 16, 2019·4 cites·4 claims
- 4690US7547728B2Treating muscle wasting with selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2002·Granted Jun 16, 2009·40 cites·84 claims
- 4790US7214693B2Heterocyclic selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2003·Granted May 8, 2007·33 cites·63 claims
- 4889US10597354B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofGTX INC·Filed 2018·Granted Mar 24, 2020·7 cites·20 claims
- 4989US7968603B2Solid forms of selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2008·Granted Jun 28, 2011·5 cites·6 claims
- 5089US7919647B2Selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2006·Granted Apr 5, 2011·6 cites·3 claims
Showing the top 50 of 157 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James T. Dalton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →